Pharma Mar SA 2018 SR
The report highlights PharmaMar Group's commitment to sustainability and R&D, ranking as the top Spanish company for R&D investment relative to revenue in 2018. The company focuses on marine-derived oncology treatments and consumer chemicals, maintaining ISO 14001 and OHSAS 18001 certifications. Key achievements include a workforce comprised of 56% women and significant progress in clinical trials for new cancer therapies. Environmental efforts are aligned with SDG 14, emphasizing selective marine sample collection to minimize ecosystem impact. The report also details the group's adherence to Law 11/2018 and GRI Standards for non-financial reporting.
Company: Pharma Mar SA
Sector: Manufacturing
Country: Spain
Year: 2018
Type: SR
Pages: 60
Back to company
Pharma Mar SA
Consolidated Non-Financial Information Statement
The report highlights PharmaMar Group's commitment to sustainability and R&D, ranking as the top Spanish company for R&D investment relative to revenue in 2018. The company focuses on marine-derived oncology treatments and consumer chemicals, maintaining ISO 14001 and OHSAS 18001 certifications. Key achievements include a workforce comprised of 56% women and significant progress in clinical trials for new cancer therapies. Environmental efforts are aligned with SDG 14, emphasizing selective marine sample collection to minimize ecosystem impact. The report also details the group's adherence to Law 11/2018 and GRI Standards for non-financial reporting.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2018
Reporting Period
Jan 1, 2018 - Dec 31, 2018
Fiscal Year
2018
Published
Feb 28, 2019
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
Sustainable Development Goals
Other Standards
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Water Consumption
Women on Board
Women in Management
Employees